about
A Review of Experimental and Off-Label Therapies for Clostridium difficile InfectionNext-generation precision antimicrobials: towards personalized treatment of infectious diseases.Evaluation of the electron transfer flavoprotein (ETF) as an antibacterial target in Burkholderia cenocepacia.Challenges and Opportunities of Nontraditional Approaches to Treating Bacterial Infections.Advances in therapeutic bacterial antisense biotechnology.The antibacterial effect of topical ozone on the treatment of MRSA skin infection.Amikacin: Uses, Resistance, and Prospects for Inhibition.
P2860
Q30240264-20CBAAB8-7A76-45E6-AA1A-B2A35063FA09Q39379540-0058A462-6A96-4D8E-81BE-2E2004858DF8Q40089786-E8B2DE4A-2897-499D-AF8F-F64E1427CDFFQ41859542-3F5B39A4-E390-4A5D-9EC6-E73AA28406E2Q47325247-4358DC54-4182-43D0-A551-CAE250837409Q47768846-1ACDF4B8-415B-445B-9C62-88C1E0AA25DAQ52744431-117A342E-E303-4874-AA5E-618AA6A4E0E7
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Antisense antimicrobial therapeutics
@en
type
label
Antisense antimicrobial therapeutics
@en
prefLabel
Antisense antimicrobial therapeutics
@en
P2860
P1476
Antisense antimicrobial therapeutics
@en
P2093
Bruce L Geller
Erin K Sully
P2860
P356
10.1016/J.MIB.2016.05.017
P577
2016-06-29T00:00:00Z